Longbow Research Upgrades Sigma Aldrich (SIAL) to Buy
More News related to SIAL
- Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009
- Sigma-Aldrich Launches 'What's Your Favorite Gene?' Application On Facebook(R) Platform
- Sigma-Aldrich (SIAL) Declares $0.145 Quarterly Dividend; 1% Yield
- Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
- Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
Longbow Research upgrades Sigma Aldrich (Nasdaq: SIAL) to Buy from Neutral. Price target $65.
To see more analyst ratings on SIAL Click Here.
Sigma-Aldrich Corporation, together with its subsidiaries, develops, manufactures, purchases, and distributes various biochemicals and organic chemicals worldwide.
Related Categories
UpgradesStocks Mentioned
-1.31Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
